Myosin Therapeutics Inc. — Form D/A
Myosin Therapeutics Inc. of JUPITER, FL, a company, filed a Form D amendment with the SEC on 2023-03-24. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-03-24
- Form: D/A
- Accession: 0001958190-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 4
- Date of first sale: 2022-12-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-467831
Issuer
- Name: Myosin Therapeutics Inc.
- CIK: 0001958190
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 130 SCRIPPS WAY, 3B3, JUPITER, FL, 33458
- Phone: 1-844-696-7469
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Dave Adams | Director | Jupiter, FL |
| Robert Finizio | Director | Phoenixville, PA 19460, PA |
| Patrick Griffin, Ph.D. | Director | Jupiter, FL |
| Theodore Kamenecka | Director | Jupiter, FL |
| Courtney Miller | Director | Jupiter, FL |
| Andrew Ritter | Director | SAN FRANCISCO, CA |
| Jackson Streeter | Director | Middletown, PA |
| Courtney Miller | Executive Officer | Jupiter, FL |
Other filings by this issuer (1)
More